KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Non Operating Income (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Non Operating Income for 17 consecutive years, with $28.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income changed N/A to $28.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $89.5 million, a N/A change, with the full-year FY2025 number at $90.3 million, changed 0.0% from a year prior.
  • Non Operating Income was $28.6 million for Q4 2025 at Bio-Rad Laboratories, up from $8.3 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $50.4 million in Q1 2023 to a low of -$579000.0 in Q3 2021.
  • A 5-year average of $16.3 million and a median of $13.3 million in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: crashed 157.9% in 2021, then soared 7089.58% in 2022.
  • Bio-Rad Laboratories' Non Operating Income stood at $10.0 million in 2021, then tumbled by 77.18% to $2.3 million in 2022, then soared by 619.06% to $16.5 million in 2023, then increased by 9.78% to $18.1 million in 2024, then surged by 58.01% to $28.6 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Non Operating Income are $28.6 million (Q4 2025), $8.3 million (Q3 2025), and $18.1 million (Q2 2024).